logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
D

David A. Cairns

University of Leeds
H指数:44
被引数:7,485

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Neoadjuvant durvalumab plus chemotherapy in resectable or borderline resectable non-small-cell lung cancer: the phase 2 MDT-BRIDGE trial

新辅助度伐利尤单抗联合化疗在可切除或临界可切除非小细胞肺癌中的应用：MDT-BRIDGE II期临床试验

Nature Medicine
IF50
2026-10-260
OAAI
Martin Reck; Ernest Nadal; Carl M. Gay; Nicolas Girard; Andrea Riccardo Filippi; Linda W. Martin; Cordula Petersen; David A. Cairns; Margarita Majem; Andrea Ardizzoni; Rosa Alvarez Alvarez; Andrew Robinson; Benoit Roch; Arnaud Boyer; Ilaria Attili; Maximilian Diehn; David Kurtz; Ugochinyere A. Emeribe; Ignacio Diaz Perez; Matteo Giaj Levra; Davina Gale; Zhou Zhu; Nefeli Georgoulia; Jonathan Spicer
TLR9-dependent migration identifies different Chronic Lymphocytic Leukemia signaling states under BTK inhibition.

TLR9依赖性迁移识别BTK抑制下慢性淋巴细胞白血病的不同信号状态。

Blood
IF23.1
2026-10-070
OAAI
Emma Kennedy; Lauren Stott; Iona Ashworth; Eleni Ladikou; John Jones; Rosalynd Johnston; Aimilia Vareli; Valter Gattei; Antonella Zucchetto; Triantafillos Liloglou; Piers Patten; Sandrine Jayne; Martin J.S. Dyer; Sean Girvan; David A. Cairns; Fabio Simoes; Simon Mitchell; Chris Pepper; Andrea G.S. Pepper
Clinical, cytogenetic, and germline genetic determinants of arterial thromboembolism in IMiD-treated multiple myeloma

IMiD治疗的多发性骨髓瘤患者动脉血栓栓塞的临床、细胞遗传学和胚系遗传决定因素

Blood Cancer Journal
IF11.6
2026-09-240
OA
Sina A. Beer; David A. Cairns; Molly Went; Philip Law; Amy Holroyd; Elsa Ferris; Charlotte Pawlyn; Gordon Cook; Mark Drayson; Kevin Boyd; Faith E. Davies; Matthew Jenner; Gareth J. Morgan; Graham Jackson; Richard Houlston; Martin F. Kaiser
Blood Cancer Clinical Trials Long-term Follow-up Using Integrated Healthcare Systems Data (BLISS): protocol for a data-linkage study integrating randomised clinical trials with national healthcare systems data

利用整合医疗系统数据的血液癌症临床试验长期随访（BLISS）：一项整合随机临床试验与国家医疗系统数据的链接研究方案

BMJ Open
IF2.3
2026-05-110
PRE
Smith, Lesley; Hoang, Janice; Gillson, Sharon; Richards, Jeanine; Cook, Gordon; Brown, Sarah; Royle, Kara-Louise; Roberts, Sadie; Olivier, Catherine; Parish, Chris; Spencer, Katie; Thompson, Shelagh; Cairns, David A.
The density of tumour infiltrating lymphocytes in oesophago-gastric cancer varies with disease stage, geographical region and treatment: a post hoc analysis of nine phase III clinical trials

食管胃癌中肿瘤浸润淋巴细胞的密度随疾病分期、地理区域和治疗而变化：九项III期临床试验的事后分析

Gastric Cancer
IF5.1
2026-05-050
OAAI
Georgina A. Keogh; Nina Šefčovičová; Tomio Arai; Myeong-Cherl Kook; Jon P. Laye; William H. Allum; Sameira Arif; Avani Athauda; Hee Kyung Chang; Jae-Ho Cheong; Mee-Yon Cho; David Cunningham; Lara Heij; Andrew F. Irvine; Hee Sung Kim; Hyunki Kim; Young-Woo Kim; Ruth E. Langley; Sung Hak Lee; Katharina von Loga; Matthew G. Nankivell; Takashi Oshima; Russell D. Petty; Xiuxiang Tan; Shiro Tanaka; Akira Tsuburaya; Judith de Vos-Geelen; Nicholas P. West; Jake Emmerson; Jamie R. Stokes; Derek R. Magee; David A. Cairns; Heike I. Grabsch
Machine learning risk stratification strategy for multiple myeloma: Insights from the EMN–HARMONY Alliance platform

基于EMN–HARMONY联盟平台的机器学习风险分层策略用于多发性骨髓瘤：见解

HemaSphere
IF14.6
2025-10-090
OAAI
Adrian Mosquera Orgueira; Marta Sonia Gonzalez Perez; Mattia D'Agostino; David A. Cairns; Alessandra Larocca; Juan José Lahuerta Palacios; Ruth Wester; Uta Bertsch; Anders Waage; Elena Zamagni; Carlos Pérez Míguez; Javier Alberto Rojas Martínez; Elias K. Mai; Davide Crucitti; Hans Salwender; Daniele Dall'Olio; Gastone Castellani; Manuel Piñeiro Fiel; Sara Bringhen; Sonja Zweegman; Michele Cavo; Sofía Iqbal; Jesus Maria Hernandez Rivas; Benedetto Bruno; Gordon Cook; Martin F. Kaiser; Hartmut Goldschmidt; Niels W. C. J. Van De Donk; Graham Jackson; Jesús F. San-Miguel; Mario Boccadoro; Maria-Victoria Mateos; Pieter Sonneveld
Ixazomib as consolidation and maintenance versus observation in patients with relapsed multiple myeloma eligible for salvage autologous stem-cell transplantation (Myeloma XII [ACCoRD]): interim analysis of a multicentre, open-label, randomised, phase 3 trial
LANCET HAEMATOLOGY
IF17.7
2024-11-010
OAAI
Cook, Gordon; Ashcroft, A. John; Senior, Ethan; Olivier, Catherine; Hockaday, Anna; Richards, Jeanine; Cavenagh, Jamie D.; Snowden, John A.; Drayson, Mark T.; de Tute, Ruth; Roberts, Lesley; Owen, Roger G.; Yong, Kwee; Garg, Mamta; Boyd, Kevin; Sati, Hamdi; Gillson, Sharon; Cook, Mark; Cairns, David A.; Parrish, Christopher
Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm

无进展生存期作为骨髓瘤临床试验的替代终点: 一个不断发展的范式

BLOOD CANCER JOURNAL
IF11.6
2024-08-121
OAAI
Pawlyn, Charlotte; Schjesvold, Fredrik H.; Cairns, David A.; Wei, L. J.; Davies, Faith; Nadeem, Omar; Abdulhaq, Haifaa; Mateos, Maria-Victoria; Laubach, Jacob; Weisel, Katja; Ludwig, Heinz; Rajkumar, S. Vincent; Sonneveld, Pieter; Jackson, Graham; Morgan, Gareth; Richardson, Paul G.
An investigation of the clinical impact and therapeutic relevance of a DNA damage immune response (DDIR) signature in patients with advanced gastroesophageal adenocarcinoma
ESMO OPEN
IF8.3
2024-05-011
OAAI
Baxter, M. A.; Spender, L. C.; Cairns, D.; Walsh, S.; Oparka, R.; Porter, R. J.; Bray, S.; Skinner, G.; King, S.; Turbitt, J.; Collinson, D.; Miedzybrodzka, Z. H.; Jellema, G.; Logan, G.; Kennedy, R. D.; Turkington, R. C.; Mclean, M. H.; Swinson, D.; Grabsch, H. I.; Lord, S.; Seymour, M. J.; Hall, P. S.; Petty, R. D.
Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease

以可测量的残留疾病为指导的慢性淋巴细胞白血病治疗

NEW ENGLAND JOURNAL OF MEDICINE
IF78.5
2024-01-2550
OA
Munir, Talha; Cairns, David A.; Bloor, Adrian; Allsup, David; Cwynarski, Kate; Pettitt, Andrew; Paneesha, Shankara; Fox, Christopher P.; Eyre, Toby A.; Forconi, Francesco; Elmusharaf, Nagah; Kennedy, Ben; Gribben, John; Pemberton, Nicholas; Sheehy, Oonagh; Preston, Gavin; Schuh, Anna; Walewska, Renata; Duley, Lelia; Howard, Dena; Hockaday, Anna; Jackson, Sharon; Greatorex, Natasha; Girvan, Sean; Bell, Sue; Brown, Julia M.; Webster, Nichola; Dalal, Surita; de Tute, Ruth; Rawstron, Andrew; Patten, Piers E. M.; Hillmen, Peter
Maintenance lenalidomide in newly diagnosed transplant eligible and non-eligible myeloma patients; profiling second primary malignancies in 4358 patients treated in the Myeloma XI Trial

来那度胺在新诊断的符合移植条件和不符合移植条件的骨髓瘤患者中的维持治疗; 在骨髓瘤XI试验中治疗的4358例患者中分析第二原发性恶性肿瘤

ECLINICALMEDICINE
IF10
2023-08-015
OAAI
Jones, John R.; Cairns, David A.; Menzies, Tom; Pawlyn, Charlotte; Davies, Faith E.; Sigsworth, Rachel; Brioli, Annamaria; Jenner, Matthew W.; Kaiser, Martin F.; Olivier, Catherine; Reed, Molly; Drayson, Mark T.; Owen, Roger G.; Boyd, Kevin D.; Cook, Gordon; Morgan, Gareth J.
NET-02: a randomised, non-comparative, phase II trial of nal-IRI/5-FU or docetaxel as second-line therapy in patients with progressive poorly differentiated extra-pulmonary neuroendocrine carcinoma

NET-02: ni-iri/5-FU或多西他赛作为进行性低分化肺外神经内分泌癌患者二线治疗的随机，非比较，II期试验

ECLINICALMEDICINE
IF10
2023-06-018
OAAI
McNamara, Mairead G.; Swain, Jayne; Craig, Zoe; Sharma, Rohini; Faluyi, Olusola; Wadsley, Jonathan; Morgan, Carys; Wall, Lucy R.; Chau, Ian; Reed, Nick; Sarker, Debashis; Margetts, Jane; Krell, Daniel; Cave, Judith; Sothi, Sharmila; Anthoney, Alan; Bell, Christopher; Patel, Alkesh; Oughton, Jamie B.; Cairns, David A.; Mansoor, Wasat; Lamarca, Angela; Hubner, Richard A.; Valle, Juan W.

研究方向

暂未获取到该数据
M
Martin Kaiser
H 指数:61论文数:452被引数:1.2万
G
Graham Jackson
H 指数:70论文数:489被引数:1.7万
F
Faith E. Davies
H 指数:98论文数:1,154被引数:4.0万
G
Gareth J. Morgan
H 指数:124论文数:1,932被引数:7.1万
M
Mark T. Drayson
H 指数:77论文数:750被引数:2.3万
G
Gordon Cook
H 指数:80论文数:770被引数:2.2万
R
Rosamonde E. Banks
H 指数:73论文数:381被引数:2.9万
R
Roger G. Owen
H 指数:60论文数:543被引数:1.7万
C
Charlotte Pawlyn
H 指数:37论文数:263被引数:6,492
P
Peter J. Selby
H 指数:86论文数:581被引数:2.8万